Delivery Order SPE2DB22D3010-SPE2DB25FP2PS
Award Date
5/29/25
Potential Completion Date
5/30/25
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,530.43, is for the delivery of 60 tablets of valganciclovir 450 mg. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The contract has a completion date of March 12, 2025 and was awarded on March 11, 2025. This award is not designated as a set-aside contract....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 60-count bottles of the drug Valganciclovir 450 mg tablets, with a ceiling value of $3,193.93 and a period of performance through April 14, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a large pharmaceutical distributor and healthcare solutions provider. The $8,386.87 firm fixed-price delivery order is for 60 tablets of the medication valganciclovir 450 mg. The contract has a period of performance through July 9, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,147.05 firm fixed-price delivery order is for the supply of 60 tablets of 450 mg Valganciclovir, a medication used to treat cytomegalovirus infections. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,191.08 firm fixed-price delivery order is for the supply of 4563033480 - Valganciclovir HCL 50 MG/ML 88ML, with a period of performance ending on December 8, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $3,507.63, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 60 units of 450 mg Valganciclovir tablets, a medication used for the treatment of cytomegalovirus (CMV) infections. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of December 31, 2024. AmerisourceBergen holds a...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an award value of $1,668.46 and is for the delivery of valganciclovir 450 mg tablets. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is November 15, 2023. This award is not designated as a set-aside contract. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,941.22 Firm Fixed Price delivery order is for the supply of 60 tablets of 450 mg Valganciclovir, a medication used to treat cytomegalovirus infections. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,948.63 firm fixed-price delivery order is for the supply of 4558106928 valganciclovir HCL 50 mg/ml medication. The contract has an ultimate completion date of August 16, 2022 and was awarded on August 15, 2022. No set-aside was used for this open competition contract. AmerisourceBergen holds a $999,999,999...
This federal contract award, with an ID of SPE2DB22D3004|SPE2DB25FPG03, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Valganciclovir 450 mg tablets, a medication used to treat certain viral infections. The contract has a ceiling value of $2,530.98 and a performance period ending on January 28, 2025. It is a firm fixed-price delivery order contract, with...